Electromedical Technologies, Inc (EMED) stock
EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)
Close on Oct 19, 2026Market cap $68.10KP/E –Yield –
Electromedical Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Electromedical Technologies's R&D Expenses for the twelve months ending Dec 31, 2020 was $31.60K, down 61.9% year over year. For fiscal 2023 it was $231.43K, up 150.7% from the year before. The highest annual figure on record is $231.43K in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $231.43K | +150.7% |
| FY2022 | Dec 31, 2022 | $92.30K | -57.1% |
| FY2021 | Dec 31, 2021 | $215.32K | +581.4% |
| FY2020 | Dec 31, 2020 | $31.60K | -61.9% |
| FY2019 | Dec 31, 2019 | $82.85K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $31.60K | +117.5% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $47.24K | – |
| Q3 FY2019 | Sep 30, 2019 | $14.53K | – |
| Q2 FY2019 | Jun 30, 2019 | $21.08K | – |
See a number that looks wrong?